Skip to content

Safety and efficacy of different doses of butorphanol in operation under general anesthesia

Safety and efficacy of different doses of butorphanol in operation under general anesthesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022868
Enrollment
Unknown
Registered
2019-04-28
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective general anesthesia

Interventions

butorphanol group (B1, B2, B3):intravenous butorphanol

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Obese patients undergoing laparoscopic upper abdominal surgery; 2. Aged 18~60 years; 3. ASA I-II; 4. BMI 18-30; 5. The time of operation 2-4h; 6. Sign written informed consent and unwilling to abide by research protocols approved by the investigator.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breastfeeding; 2. Liver and kidney disease; 3. Hb<90g/L; 4. Preoperative severe impairment of respiratory function; 5. Pulmonary hypertension; 6. Heart failure, coronary heart disease, myocardial infarction; 7. Subjects has contraindication for butorphanol; 8. Patients with preoperative hypoxemia(SPO2<95%) 9. Subjects considered by the investigator to have any other factors not suitable for participation in the clinical study.

Design outcomes

Primary

MeasureTime frame
Hypoxic frequency after extubation;

Secondary

MeasureTime frame
Opioid dosages;

Countries

China

Contacts

Public ContactLiu Su

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

150040009@qq.com+86 18118309692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026